Live Breaking News & Updates on Grifols Company Profile

Stay updated with breaking news from Grifols company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Grifols, S.A. (NASDAQ:GRFS) Short Interest Up 18.5% in May

Grifols, S.A. (NASDAQ:GRFS – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 7,950,000 shares, a growth of 18.5% from the April 30th total of 6,710,000 shares. Based on an average trading volume of 2,210,000 shares, the […] ....

United States , Creek Investment Management Inc , Deutsche Bank Aktiengesellschaft , Grifols Company Profile , First Trust Advisors , Norges Bank , Get Free Report , World Investors , Investment Partners , Creek Investment Management , Trust Advisors , Grifols Daily ,

Grifols, S.A. (NASDAQ:GRFS) Receives Average Recommendation of "Hold" from Brokerages

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Free Report) have earned an average recommendation of “Hold” from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. GRFS has been the […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , Wells Fargo Company , Orion Portfolio Solutions , Morgan Stanley , Grifols Company Profile , Get Free Report , Marketbeat Ratings , Capital Management , Portfolio Solutions , Get Free , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Grifols, S.A. (NASDAQ:GRFS) Given Consensus Rating of "Hold" by Analysts

Grifols, S.A. (NASDAQ:GRFS – Get Free Report) has been assigned a consensus rating of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price target among […] ....

Nova Scotia , United States , Vistaseal Veraseal , Albutein Flexbag , Morgan Stanley , Raymond James Associates , Grifols Company Profile , Blackrock Inc , Financial Services Group Inc , Advisor Group Holdings Inc , Us Bancorp , Get Free Report , Marketbeat Ratings , Group Holdings , Services Group , Get Free , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,

Morgan Stanley Lowers Grifols (NASDAQ:GRFS) to Equal Weight

Morgan Stanley lowered shares of Grifols (NASDAQ:GRFS – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday morning, FlyOnTheWall reports. Separately, StockNews.com began coverage on Grifols in a research report on Thursday, August 17th. They set a hold rating for the company. Five investment analysts have rated […] ....

United States , Albutein Flexbag , Vistaseal Veraseal , Financial Services Group Inc , Morgan Stanley , Quadrant Capital Group , Grifols Company Profile , Free Report , Get Free Report , Financial Advisors , Capital Group , Services Group , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily , Nasdaq Grfs ,